about
Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II TrialCytokines in cancer immunotherapy.Introduction to the role of the immune system in melanoma.Hemorrhagic collision metastasis in a cerebral arteriovenous malformation.After a treatment breakthrough-progress, plateaus, and raising the bar.Treatment of Renal Cell Cancer With Programmed Cell Death 1 Blockade: How Much Is Enough?Kidney cancer, version 2.2014.Brain Metastases in Melanoma: Moving Toward Curing the Incurable.Hemorrhagic collision metastasis in a cerebral arteriovenous malformation.Human breast tumor-infiltrating CD8 T cells retain polyfunctionality despite PD-1 expressionCytokine therapy in cancerThe significance of solid tumor stem cells in melanoma: Part 2
P50
Q36726204-1070CF84-0202-46E9-BE79-3A6A4ADA9848Q37148152-8A1AD9E1-5498-49E1-8062-2B2BA4952373Q38216376-39A4B1C9-E65B-4812-BDAC-563902366B4EQ41961466-1616FB4C-39E7-4106-812A-8C64B2C60436Q46492858-89F0E90F-AFDD-4D29-88BC-131B1FE1F84BQ46788117-448F0167-4A01-4746-B551-54C991CE91DBQ47605459-E27FA6FC-5CD9-4EA5-A3E9-C7E3CFFAE886Q47617510-C9496F32-A6F1-4D80-837F-7A3BE1979ACFQ48511079-368FFEA2-C277-4030-8FF1-B60232A97C27Q57459367-AF781DD7-07FC-4C6F-9DB8-811DD0699B17Q94706486-8974EDCC-D6A2-434C-9483-0547B1CA604BQ95807420-3C5C09E5-043D-42AA-ABE6-BCBA7C7EBD9F
P50
description
researcher (ORCID 0000-0002-5248-4356)
@en
wetenschapper
@nl
باحث (معرف أورسيد 0000-0002-5248-4356)
@ar
name
Kim Margolin
@en
Kim Margolin
@nl
type
label
Kim Margolin
@en
Kim Margolin
@nl
prefLabel
Kim Margolin
@en
Kim Margolin
@nl
P31
P496
0000-0002-5248-4356